GINA HIGGINS: Open Payments
NPI 1114110160 · HOLYOKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,908 in 121 payments from 16 companies in 2025. Trend: 2023 $248 · 2024 $1,904 · 2025 $2,908
Food & beverage: $2,908
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 26 | $630 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $510 |
| Vanda Pharmaceuticals Inc. | 10 | $279 |
| Teva Pharmaceuticals USA, Inc. | 7 | $219 |
| Janssen Pharmaceuticals, Inc | 5 | $209 |
| Otsuka America Pharmaceutical, Inc. | 9 | $185 |
| Supernus Pharmaceuticals, Inc. | 11 | $183 |
| Corium, LLC | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $102 |
| Indivior Inc. | 3 | $101 |
Products named: COBENFY, CAPLYTA, FANAPT, UZEDY, Qelbree, ABILIFY ASIMTUFII, SPRAVATO, REXULTI.
Industry payments across MA — which companies pay providers there.
